Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Expert Opinion / Cases · September 15, 2021

Recurrent Pancreatitis Due to Hypertriglyceridemia in a Patient With Poor Glycemic Control

 Anika Anam MD
Written by

 

Discuss This item Follow

No comments yet, be the first to start the discussion!

  • Ioan Andrei Veresiu

    Sep 17, 2021

    Adding insulin is, in my opinion, the rational decision.

  • Melvyn Rubenfire

    Sep 17, 2021

    agree to add insulin

  • Gurdeep Sethi

    Sep 17, 2021

    I would add Basal insulin and DPP4. For glycolic control and for TG's I will replace Gemfibrogyl with lipaglyn 4 mg

  • Nagaram Reddy

    Sep 17, 2021

    I would start SGLT2 inhibitor like empagliflozin starting dose of 10 mg OD 

  • AHMED ALKAREEM

    Sep 17, 2021

    I suggest testing prolactin before making disease worse ..

  • John Whillier

    Sep 18, 2021

    Give her a CGM to find out what is really driving her condition, not the theoretical assumptions.

  • Ruddy Brown

    Sep 22, 2021

    How do you address the severe muscle aches?

  • S. Edany

    Nov 17, 2021

    SGL2i for DM tx+ EPA for high TG

  • Nagaram Reddy

    Dec 11, 2021

    I would add Empagliflozin start with 10 mg OD and after one month increase to 25 Mg OD, also consider adding Semaglutide start with 0.5 Mg Sub Cut weekly and gradually increase as needed can go up to 2 mg 
    If need we can add sitagliptin

  • Dec 22, 2024

    Pending Moderator approval.
    Delete

Further Reading